Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Zomedica Pharmaceuticals Corp (ZOM)

Zomedica Pharmaceuticals Corp (ZOM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,156,305
  • Shares Outstanding, K 564,051
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,780 K
  • 60-Month Beta 0.53
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 28.60
Trade ZOM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.00
  • Number of Estimates 1
  • High Estimate 0.00
  • Low Estimate 0.00
  • Prior Year -0.03
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.85 +123.40%
on 01/27/21
2.91 -34.75%
on 02/08/21
+0.88 (+86.17%)
since 01/25/21
3-Month
0.13 +1,353.98%
on 11/27/20
2.91 -34.75%
on 02/08/21
+1.77 (+1,414.27%)
since 11/25/20
52-Week
0.06 +2,923.73%
on 11/03/20
2.91 -34.75%
on 02/08/21
+1.65 (+659.56%)
since 02/25/20

Most Recent Stories

More News
Thinking about buying stock in Diffusion Pharmaceuticals, Northern Dynasty Minerals, Zomedica, Sundial Growers, or Citius Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DFFN, NAK, ZOM, SNDL, and CTXR.

NAK : 0.7122 (-6.29%)
ZOM : 1.91 (-6.83%)
SNDL : 1.4200 (-2.07%)
CTXR : 2.14 (-3.60%)
DFFN : 1.0790 (-6.98%)
Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the underwriter of its...

ZOM.VN : 0.285 (-6.56%)
ZOM : 1.91 (-6.83%)
What's in Store for Zomedica (ZOM)This Earnings Season?

Zomedica (ZOM) may provide an update on Truforma commercialization progress when it reports fourth-quarter 2020 results.

ZOM : 1.91 (-6.83%)
BHC : 31.22 (+0.55%)
PSNL : 31.64 (-8.79%)
BCEL : 18.03 (-1.96%)
Zomedica Corp. Announces Closing of $173.5 Million Bought Deal

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that the closing of its previously...

ZOM.VN : 0.285 (-6.56%)
ZOM : 1.91 (-6.83%)
Thinking about buying stock in Aphria, Zomedica, Aurora Cannabis, Iterum Therapeutics, or Globalstar?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APHA, ZOM, ACB, ITRM, and GSAT.

ACB.TO : 14.03 (-3.51%)
GSAT : 1.7450 (-11.42%)
ZOM : 1.91 (-6.83%)
APHA : 18.79 (-6.38%)
ITRM : 1.8700 (-1.58%)
ACB : 11.08 (-4.81%)
Thinking about buying stock in Zomedica, Zynerba Pharmaceuticals, Cronos Group, Hexo Corp, or AzurRx BioPharma?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, ZYNE, CRON, HEXO, and AZRX.

ZOM : 1.91 (-6.83%)
CRON : 11.05 (-3.16%)
ZYNE : 4.59 (-8.38%)
AZRX : 1.5330 (-9.29%)
HEXO : 7.20 (-7.34%)
Why are Shares of Zomedica Surging?

Pet care stocks have been on a solid run of late as homebound lifestyles have caused more Americans to adopt pets. Against this backdrop, we think shares of veterinary diagnostic company Zomedica Corp....

ZOM : 1.91 (-6.83%)
Thinking about buying stock in Sundial Growers, Zomedica, AMC Entertainment, Senseonics, or Nokia?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, ZOM, AMC, SENS, and NOK.

AC : 36.00 (+3.27%)
SENS : 3.78 (-12.09%)
ZOM : 1.91 (-6.83%)
SNDL : 1.4200 (-2.07%)
AMC : 8.97 (-1.32%)
NOK : 4.09 (+1.24%)
Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that, due to demand, the...

ZOM.VN : 0.285 (-6.56%)
ZOM : 1.91 (-6.83%)
Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares

Zomedica Corp. (NYSE American: ZOM), ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it has entered into...

ZOM.VN : 0.285 (-6.56%)
ZOM : 1.91 (-6.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zomedica Corp. is a veterinary health company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica Corp., formerly known as Zomedica Pharmaceuticals Corp., is based in Ann Arbor, Michigan.

See More

Key Turning Points

3rd Resistance Point 2.34
2nd Resistance Point 2.26
1st Resistance Point 2.16
Last Price 1.91
1st Support Level 1.98
2nd Support Level 1.90
3rd Support Level 1.80

See More

52-Week High 2.91
Last Price 1.91
Fibonacci 61.8% 1.82
Fibonacci 50% 1.49
Fibonacci 38.2% 1.15
52-Week Low 0.06

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar